Djuna L Cahen Selected Research

Incretins

4/2016	GLP-1 based therapies: clinical implications for gastroenterologists.
11/2015	Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Djuna L Cahen Research Topics

Disease

7	Chronic Pancreatitis 01/2018 - 02/2007
6	Type 2 Diabetes Mellitus (MODY) 01/2021 - 11/2015
5	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 08/2012
4	Adenocarcinoma 06/2022 - 11/2016
4	Pathologic Constriction (Stenosis) 01/2020 - 01/2005
3	Neoplasms (Cancer) 06/2022 - 01/2020
3	Pain (Aches) 04/2012 - 02/2007
2	Body Weight (Weight, Body) 01/2021 - 04/2016
2	Overweight 03/2017 - 12/2016
2	Pancreatitis 11/2015 - 01/2005
2	Steatorrhea 08/2012 - 01/2012
1	Diabetes Mellitus 11/2022
1	Dizziness (Lightheadedness) 12/2016
1	Fibrosis (Cirrhosis) 12/2016
1	Gallstones (Gallstone) 12/2016
1	Autoimmune Pancreatitis 11/2016
1	Sclerosing Cholangitis 11/2016
1	Neoplasms, Cystic, Mucinous, and Serous 05/2016
1	Acute Kidney Injury (Acute Renal Failure) 11/2015
1	Heart Failure 11/2015
1	Osteoporosis 05/2013
1	Metabolic Bone Diseases (Osteopenia) 05/2013
1	Cholangitis 04/2012
1	Cholecystitis 04/2012
1	Exocrine Pancreatic Insufficiency 01/2012
1	Malnutrition (Nutritional Deficiencies) 01/2012
1	Weight Loss (Weight Reduction) 01/2012
1	Ileitis 08/2008
1	Crohn Disease (Crohn's Disease) 08/2008
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2008

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 11/2022 - 12/2020
4	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 12/2016
4	Liraglutide FDA Link 01/2021 - 12/2016
4	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 12/2016
4	EnzymesIBA 03/2017 - 01/2012
3	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 12/2016 - 11/2015
2	PlasticsIBA 01/2018 - 04/2012
2	Glucagon-Like Peptides (Enteroglucagon)IBA 12/2016 - 11/2015
2	Pharmaceutical PreparationsIBA 12/2016 - 04/2016
2	IncretinsIBA 04/2016 - 11/2015
2	Dietary Fats (Dietary Fat)IBA 08/2012 - 01/2012
1	Proteins (Proteins, Gene)FDA Link 11/2022
1	Interleukin-8 (Interleukin 8)IBA 11/2022
1	MicroRNAs (MicroRNA)IBA 06/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2021
1	Chenodeoxycholic Acid (Chenix)FDA Link 01/2021
1	Cholic AcidIBA 01/2021
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 01/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 12/2016
1	PlacebosIBA 12/2016
1	AntibodiesIBA 11/2016
1	Pregnenolone Carbonitrile (PCN)IBA 05/2016
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2016
1	LipidsIBA 04/2016
1	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2016
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 04/2016
1	VitaminsIBA 05/2013
1	Analgesics (Analgesic Drugs)IBA 04/2012
1	SteroidsIBA 08/2008
1	Immunomodulating AgentsIBA 08/2008
1	Infliximab (Remicade)FDA Link 08/2008

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2005
3	Stents 01/2018 - 01/2005
2	Self Expandable Metallic Stents 01/2020 - 04/2012
2	Length of Stay 11/2011 - 02/2007
1	Radiofrequency Ablation 01/2021
1	Liver Transplantation 04/2012
1	Cholecystectomy 04/2012
1	Immunomodulation 08/2008
1	Decompression 02/2007